GenSpera Inc. – “Value and Understanding What is Valuable Over Time”

NEW YORK, NY / ACCESSWIRE / May 7, 2015 / GenSpera Inc. (OTCQB: GNSZ) today published a new blog post on The Chairman’s Blog, written by the Company’s chief executive officer, Dr. Craig A. Dionne, Ph.D. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

Following yesterday’s announcement regarding the expansion of the Company’s broad intellectual property (IP) portfolio, Dr. Dionne blogged about how GenSpera continues to build intrinsic value through IP expansion, reinforcement and protection. “The value of the nanoemulsion formulation patent to GenSpera is very high. It applies to our entire family of thapsigargin-containing prodrugs and so covers all the drugs coming from our platform technology, including mipsagargin,” explained Dionne. Read the full blog post from Dr. Craig Dionne on TheChairmansBlog.com (http://www.thechairmansblog.com/genspera/craig-dionne/value-understanding-valuable-time/).

About GenSpera

GenSpera Inc. is a San Antonio-based biotech company that unlocks conventional thinking to conceive, design, and develop cancer therapies. GenSpera’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a patented prodrug delivery system that provides for targeted release of drug candidates within tumors. GenSpera’s lead drug candidate, mipsagargin, was granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) in 2013 for evaluation in patients with hepatocellular carcinoma (liver cancer).

For additional information on GenSpera, visit www.genspera.com and connect on Twitter, LinkedIn, Facebook, YouTube and Google+.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

SOURCE: TheChairmansBlog.com

ReleaseID: 428608